EcoDrugPlus

Bruton Tyrosine Kinase

Ensembl ID : ENSONIG00000002479
Gene Symbol: BTK
4 Cross references
204 Possible Orthologues:

C-C Chemokine Receptor Type 9

Ensembl ID : ENSONIG00000014025
Gene Symbol: LOC100691147
3 Cross references
188 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSONIG00000006297
Gene Symbol: CCR9
4 Cross references
193 Possible Orthologues:

C-X-C Motif Chemokine Receptor 2

Ensembl ID : ENSONIG00000004508
Gene Symbol: CXCR2
4 Cross references
275 Possible Orthologues:

C-X-C Motif Chemokine Receptor 4

Ensembl ID : ENSONIG00000004410
Gene Symbol: CXCR4
4 Cross references
201 Possible Orthologues:

C-Reactive Protein

Ensembl ID : ENSONIG00000037297
Gene Symbol: LOC109204179
2 Cross references
347 Possible Orthologues:

Cf Transmembrane Conductance Regulator

Ensembl ID : ENSONIG00000003911
Gene Symbol: CFTR
4 Cross references
214 Possible Orthologues:

D(4) Dopamine Receptor

Ensembl ID : ENSONIG00000003934
Gene Symbol: LOC102079696
4 Cross references
165 Possible Orthologues:

D(4) Dopamine Receptor

Ensembl ID : ENSONIG00000030102
Gene Symbol: LOC100693279
4 Cross references
181 Possible Orthologues:

Dna Methyltransferase 1

Ensembl ID : ENSONIG00000001574
Gene Symbol: DNMT1
3 Cross references
210 Possible Orthologues:

Dna Topoisomerase 1

Ensembl ID : ENSONIG00000020303
Gene Symbol: LOC100697672
4 Cross references
207 Possible Orthologues:

Dna Topoisomerase I

Ensembl ID : ENSONIG00000017441
Gene Symbol: TOP1
1 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).